PURPOSE
The purpose of this study was to analyze the outcomes of treatment of acute postoperative endophthalmitis and verify its main causative agents.
MATERIAL AND METHODS
The study included 49 patients (49 eyes) with acute postoperative endophthalmitis that developed following surgical interventions in various clinics. At the onset of endophthalmitis, 3 patients (6.1%) retained object vision with visual acuity ranging from 0.05 to 0.20, while 7 patients (14.3%) had visual acuity between 0.01 and 0.05. Visual acuity deteriorated to finger counting near face in 15 patients (30.6%), to 1/∞ pr.l.certa in 21 patients (42.9%), and to 1/∞ pr.l.incerta in 3 patients (6.1%).
All patients were treated using a new technique we developed, which involved short-term tamponade of the vitreous cavity with perfluorodecalin and intravitreal administration of antibiotics. Before treatment start, biological material was collected for bacteriological examination.
RESULTS
Visual function was preserved in 46 patients (93.9%). Clinically significant improvement in visual acuity (0.3—0.4) was observed in 36 patients (73.5%), while 6 patients (12.2%) achieved visual acuity greater than 0.5. No cases of recurrent inflammation were recorded; however, laser tyndallometry indicated a persistent disruption of the blood-ocular barrier for up to 6 months post-treatment, with a protein flow value of 14.6 (8.4; 19.2) ph/ms (p=0.002).
The most informative method for identifying the etiological cause of endophthalmitis was vitreous sampling (81.6% effectiveness), compared to anterior chamber sampling (38.8% effectiveness).
CONCLUSION
The best functional outcomes were achieved in patients with endophthalmitis caused by S. epidermidis and S. aureus. Endophthalmitis caused by gram-negative bacteria had a poor visual prognosis.